TZ-161
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TZ-161, covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury [Phase 1, Phase 2]